Catalyst
Slingshot members are tracking this event:
Top-Line Results on Solanezumab Phase 3 Clinical Trial in Patients with Alzheimer's Disease
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| LLY |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 25, 2012
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Solanezumab, Alzheimer's
